期刊文献+

前列腺癌PSA筛查:基于流行病学的证据 被引量:11

原文传递
导出
摘要 前列腺物异性抗原(PSA)检测是前列腺癌筛查主要方法。流行病学分析发现,PSA筛查早期发现者多为局限性前列腺癌,而且在筛查间隔时间和阈值等方面缺乏流行病学依据,同时,PSA筛查存在诱导过度医疗问题,因此,健康人群前列腺癌PSA筛查应局限特定人群。
出处 《公共卫生与预防医学》 2014年第6期74-76,共3页 Journal of Public Health and Preventive Medicine
关键词 前列腺癌 PSA 筛查
  • 相关文献

参考文献16

  • 1Catalona,W. J, Richie, J. P, Ahmann, F. R, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trim of 6,630 men [ J ].The Journal of urology, 1994,151 (5) : 1283-1290.
  • 2刘明,朱玲,马兰军,等.血清前列腺特异抗原(PsA)筛查在健康体检中的价值.第六届中国健康产业论坛[EB/OL],2000:112-116.http ://d.wanfangdata. com. cn/Conference_7272189, as- px.
  • 3Andriole GL, Crawford ED, Grubb RL, et al. PLGO Project Team. Mortality results from a randomized prostate-cancer screening trial [J] .N Engl J Mcd.2009,360:1310-1319.
  • 4Sehrfder FH, Hugosson J, Roohol MJ ,et al, ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study[ J] .N Engl J Mcd.2009;360:1320-1328.
  • 5朱刚,那彦群,叶定伟,李宁忱,潘铁军,邢金春,贺大林,李鸣.PSA与前列腺癌的早期诊断[J].中华泌尿外科杂志,2013,34(9):715-716. 被引量:19
  • 6Richard M.Hoffman,Michael J.Barry,Richard G.Roberts,Harold C.Sox,邵钧(翻译).前列腺癌筛查:调和初级保健和专科的视角矛盾[J].中国全科医学,2013,16(13):1451-1452. 被引量:3
  • 7American Cancer Society. Cancer Facts & Figures 2005 [ R ]. At- lanta: American Cancer Society; 2005.
  • 8江勤康,戴颖秀.上海市杨浦区1980年~1999年前列腺癌流行趋势分析[J].中国肿瘤,2002,11(5):263-264. 被引量:13
  • 9施侣元,仇成轩.前列腺癌流行病学研究进展[J].中国热带医学,2001,1(1):50-53. 被引量:7
  • 10王伟,何家扬.肥胖、代谢综合征与前列腺癌[J].现代泌尿外科杂志,2010,15(2):155-157. 被引量:4

二级参考文献89

  • 1HSING AW, CHOKKALINGAM AP. Prostate cancer epidemiology [J]. Front Biosci, 2006,11(5): 1388-1413.
  • 2HSING AW, SAKODA LC, CHUA S JR. Obesity, metabolic syndrome and prostate cancer [J]. Am J Clin Nutr, 2007,86 (suppl 3) : 843-857.
  • 3GONG Z, NEUHOUSER ML, GOODMAN PJ, et al. Obesity, diabetes and risk of prostate cancer: results from the Prostate Cancer Prevention Trial[ J]. Cancer Epidemiol Biomarkers Prev, 2006,15(10): 1977-1983.
  • 4RODRIGUEZ C, FREEDLAND SJ, DEKA A, et al. Body mass index, weight change and risk of prostate cancer in the Cancer Prevention Study Ⅱ Nutrition Cohort [J]. Cancer Epidemiol Biomarkers Prey, 2007,16(1) : 63-69.
  • 5PLATZ EA, LEITZMANN MF, RIFAI N, et al. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era [J]. Cancer Epidemiol Biomarkers Prev, 2005, 14 (5): 1262-1269.
  • 6VON HAFE P, PINA F, PEREZ A, et al. Visceral fat accumulation as a risk factor for prostate cancer [J]. Obes Res, 2004,12(12) :1930-1935.
  • 7ALBERTI KG, ZIMMET P, SHAW J, et al. The metabolic syndrome - a new worldwide definition [J]. Lancet, 2005,366 (9491) : 1059-1062.
  • 8BEEBE-DIMMER JL, DUNN RL, SARMA AV, et al. Features of the metabolic syndrome and prostate cancer in African- American men [J]. Cancer, 2007, 109(5):875-881.
  • 9TANDE AJ, PLATZ EA, FOLSOM AR. The metabolic syndrome is associated with reduced risk of prostate cancer [J]. Am J Epidemiol, 2006, 164(11): 1094-1102.
  • 10LUND HAHEIM L, WISLOFF TF, HOLME I, et al. Metabolic syndrome predicts prostate cancer in a cohort of middleaged Norwegian men followed for 27 years [J]. Am J Epidemiol, 2006,164(8) :769-774.

共引文献57

同被引文献113

引证文献11

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部